• Go to the menu
  • Go to content
Bioregate Logo RFI
Rechercher
My accountLogin
  • fr
  • en
Contact Donate
Menu
  • Bioregate
    • Missions
    • Consortium
    • Organization
    • Operational team
    • Regional skills overview
  • Skills
    • Players Network
      • Research laboratories
      • Technology platforms
      • Clinical Innovation
      • Companies
    • Innovation supports
  • Projects
    • Research projects
    • Clinical trials
    • R&D projects
    • Publications
  • Education & Training
  • Partnerships
  • Agenda & News
  • Calls for projects
  • Bioregate Forum
    • 2016 Edition
    • 2018 Edition
  1. Home
  2. Innovation

9 November 2017

SOUNDS

The purpose of this study is to document the safety, the effectiveness, the continued performance at mid and long term, the morbidity and the percent of surgical revisions of the Interstim® therapy for up to 5 years in a representative sample of French centers under real-life conditions of use.

Repair medicine
Research
Innovation
Read more

9 November 2017

SECURE

The purpose of this study is to evaluate clinical and technical success as well as safety and feasibility of the E-tegra Stent Graft System used in endovascular treatment of infrarenal aortic aneurysm.

Repair medicine
Tools for Restorative and Regenerative Medicine
Research
Innovation
Read more

9 November 2017

PRIMICISTIM

Neuromodulation is a validated option for the treatment of fecal incontinence. Safety of this original approach has been confirmed by several studies.

Repair medicine
Regenerative Medicine
Tools for Restorative and Regenerative Medicine
Research
Innovation
Read more

9 November 2017

IRIS 2

This study evaluates the safety and effectiveness of the Intelligent Retinal Implants System (IRIS V2)

Repair medicine
Tools for Restorative and Regenerative Medicine
Research
Innovation
Read more

3 November 2017

In Cell Art

General activities A fully integrated group focused on scientific researc. In-Cell-Art, is a biopharmaceutical company specializing

Regenerative Medicine
Innovation
Read more

3 November 2017

Horama

General activities HORAMA is developing innovative gene therapy medicinal products in the field of rare

Regenerative Medicine
Innovation
Read more

Previous page 1 … 3 4 5 6 7 … 10 Next page
Back to top
  • Logo RFI
  • Bioregate
  • Contact
  • Terms and conditions
  • Site map

Led by

  • Université - Nantes

Funded by

In partnership with

  • logo-lemans-universite
  • Atlanpole-Biotherapies
© 2025 Bioregate All rights reserved.